Traditional Chinese Medicine (TCM) company Eu Yan Sang has introduced health supplements from the US to its offerings, as well as Western medical practices in its newly-launched One Wellness Medical clinics, as part of its efforts in "demystifying"...
See the latest developments from health and nutrition brands across Asia-Pacific, including how Thailand's 3C Group is eyeing growth in the prebiotic sector, TCM firm Eu Yan Sang's strategies for the North American market and more.
Singapore-headquartered Traditional Chinese Medicine (TCM) company Eu Yan Sang is actively pursuing growth in North America’s health and wellness market by targeting not just the Chinese diaspora, but also those who are willing to give the category a...
Yiling Pharmaceutical has secured a deal with Nigeria to provide traditional Chinese medicine (TCM) exports to the country and sees a strong opportunity to partner with African herbal medicine manufacturers for new product development.
Hong Kong-based NOOCI has launched in United States first through its website and an online distribution platform and is expanding offline via its practitioner’s programme – with over 100 practitioners across the country signed up thus far.
Here is the round-up of the latest nutraceutical trends in Asia-Pacific, including the growing popularity of TCM-infused supplements in Singapore, Thailand’s nutra sector attracting interest from local conglomerates, and South Korea’s health supplements...
China functional food firm BuffX has outlined its strategy to outgrow the bottleneck seen in tier one and two cities – by launching powder-based ‘breakfasts’ in lower tier cities formulated using traditional Chinese medicines (TCM) concepts.
Canada’s Tait Laboratories is planning to export its digestive health supplement to China as well as pushing the concept of ‘clean’ TCM ingredients in the region on the back of a new patent for its extraction technology for citrus peels.
Integrative medicine offers vast opportunities to improve the diagnosis and treatment of patients, but more randomised clinical trials, better quality control, and clearer health indications are required, according to veteran TCM researcher Professor...
Yiling Pharmaceutical, the company behind TCM/dietary supplement product Lianhua Qingwen, said revenue from its overseas market was up 918.37 per cent in FY2020, after the product was officially recognised by the China authorities as a COVID-19 standard...
New regulations in Australia is making research on the role of complementary medicine, including Chinese medicine, to manage chronic diseases more attractive, according to a prominent researcher who stars in the 15th episode of our NutraChampion podcast.
Malaysia headquartered Ritamix Global has launched a tea modelled on a TCM formula used in China for COVID-19 treatment – but the new product is registered as food and beverage and makes no health claims.
China consumers are placing more trust in traditional Chinese medicines (TCM), with a declining interest in overseas supplement brands and functional foods with health claims, said a consumer survey funded by the High-Value Nutrition National Science...
Blackmores CEO Alastair Symington has told us the firm decided to sell its traditional Chinese medicine (TCM) and oriental botanical supplement arm Global Therapeutics amid a decline in the segments’ main retail channel – health food stores.
Australia’s Therapeutic Goods Administration (TGA) will conduct compliance checks on listed medicines that are based on TCM, Ayurveda or other traditional paradigms, with firms urged to re-evaluate their products.
A two-week clinical trial led by renowned Chinese pulmonologist Zhong Nanshan has shown that consuming the botanical TCM product Lianhua Qingwen (LH) capsules and undergoing the standard therapy can speed up recovery in COVID-19 patients.
Researchers from Asia, the Middle East, and the West are now trialling omega-3, honey, and even potato resistant starch, on top of vitamins and zinc, as they race to find products that could contribute to the fight against COVID-19 and its symptoms.
China is conducting clinical trials to assess the effectiveness and safety of combining traditional Chinese medicine (TCM) and conventional Western antiviral medicine in the treatment of patients with the novel coronavirus (COVID-19).
In this round-up of new developments happening in China’s health and nutrition supplement industry, we shed light on the upcoming consumption trends for this year, including the up-and-coming A2 milk market.
Japanese company Health Business Info is on a mission to expand the use of sika deer in dietary supplements, using it as a key ingredient to aid sleep based on a traditional Chinese medicine (TCM) concept.
Nootropics in New Zealand, cordyceps in South Korea, and the impact of China's daigou clampdown on companies like Swisse owner H&H all feature among our five most read stories on social media this month.